• August Pi i Sunyer Biomedical Research Institute

August Pi i Sunyer Biomedical Research Institute - IDIBAPS

The Institut d'Investigacions Biomèdiques August Pi i Sunyer (August Pi i Sunyer Biomedical Research Institute - IDIBAPS) is a centre for research of excellence that tackles high-prevalence, high-morbidity and high-mortality diseases. Founded in 1996, it is a public consortium whose members are the Catalan Government, the Hospital Clínic of Barcelona, the University of Barcelona’s School of Medicine and the CSIC Biomedical Research Institute in Barcelona.

It represents over 1,000 research professionals organised into around one hundred research groups. Its combination of basic and clinical research allows for a more effective transfer of the scientific advances obtained in the laboratory towards patients. With close to 1,100 articles published each year and an impact factor of over 6,000 points, it is Spain’s principal biomedical research centre.

Excellence and recognition awards

IDIBAPS leads the ranking of ISCIII grants in Catalonia between 2000 – 2012

The Research Observatory of the Institute of Catalan Studies (OR-IEC) published in his blog a report analyzing data from biomedical research projects granted by the Instituto de Salud Carlos III (ISCIII) in recent years. The data suggest that Catalonia has a great capacity to raise funds within Spain, and that the IDIBAPS plays a major role in this capacity.

According to the report, between 2000 and 2012, the ISCIII has awarded 9,020 research projects in Spain, 2,890 (32%) of which granted in Catalonia. Major health groups are the leaders of the ranking, with their participation in research institutes and/or foundations. The IDIBAPS – Hospital Clínic tandem was awarded with 671 projects.

Director of the center
Elias Campo

Elias Campo

Elias Campo is the Director of Research at the Hospital Clínic, the IDIBAPS and the Clinical Foundation for Biomedical Research and professor at the Faculty of Medicine and Health Sciences at Barcelona University. He won the Rei Jaume I Prize for Medical Research 2016 and National Research Prize 2013, Campo is an expert in the pathological characterization of lymphoid neoplasms and in the analysis of the genetic mechanisms involved in the development and progression of these tumors. In collaboration with Dr. Carlos Lopez-Otín, has co-directed the complete sequencing studies of the genome of chronic lymphatic leukemia and the epigenome of this disease. These studies, with the sequencing of the genomes of the normal and tumor cells of more than five hundred patients, have been a milestone in genomic research on cancer. Campo has been president of the European Hemopathology Association and is currently a member of the Government Committee of the International Cancer Genome Consortium and is part of the Committee for the classification of hematopoietic neoplasms of the World Health Organization (WHO).

Renowned researcher
Josep Maria Llovet

Josep Maria Llovet

Josep Maria Llovet is Professor ICREA, head of the IDIBAPS group on Translational Research in hepatic oncology and director of the Master's Degree in Translational Medicine of the Faculty of Medicine and Health Sciences of the UB. He is also the director of the Liver Cancer Program at the Ichan School of Medicine at Mount Sinai in New York. President of the International Association of Hepatic Cancer (ILCA) from 2011 to 2013, he received the Josep Trueta 2013 Prize for scientific research for his research career in the field of basic and clinical research of hepatocellular carcinoma. He is also the volume editor of Handbook of Translational Medicine (Edicions UB, 2016), a work that summarizes the basic concepts of translational medicine.